Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment. (Q38224416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

title

Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Jun Hyung Kim

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

Mi Na Kim

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

Seung Up Kim

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

publication date

19 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

1103-1115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976523 AND SRC:MED&resulttype=core&format=json

Current status of liver diseases in Korea: liver cirrhosis

21 March 2020

cites work

1 reference

Hepatitis B: liver fibrosis and hepatocellular carcinoma

21 January 2018

1 reference

Natural history of hepatitis B virus infection: an update for clinicians

21 January 2018

1 reference

Is liver fibrosis reversible?

21 January 2018

1 reference

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C

21 January 2018

1 reference

Hepatocellular carcinoma: recent trends in the United States

21 January 2018

1 reference

Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

Global cancer statistics, 2002

21 January 2018

1 reference

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

21 January 2018

1 reference

Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.

21 January 2018

1 reference

Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.

21 January 2018

1 reference

Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study.

21 January 2018

1 reference

Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression

21 January 2018

1 reference

The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

21 January 2018

1 reference

Changes of non-invasive markers and FibroScan values during HCV treatment

21 January 2018

1 reference

Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan

21 January 2018

1 reference

An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers.

21 January 2018

1 reference

Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases

21 January 2018

1 reference

Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination

21 January 2018

1 reference

Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir.

21 January 2018

1 reference

Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels

21 January 2018

1 reference

Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

21 January 2018

1 reference

Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

21 January 2018

1 reference

Histological outcome during long-term lamivudine therapy.

21 January 2018

1 reference

Introduction to chronic hepatitis B infection

21 January 2018

1 reference

Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy.

21 January 2018

1 reference

Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog

21 January 2018

1 reference

On-Treatment Monitoring of Liver Fibrosis with Transient Elastography in Chronic Hepatitis B Patients

21 January 2018

1 reference

Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives

21 January 2018

1 reference

A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis

21 January 2018

1 reference

Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.

21 January 2018

1 reference

Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy.

21 January 2018

1 reference

Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension

21 January 2018

1 reference

Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir

21 January 2018

1 reference

Risk Assessment of Hepatitis B Virus–Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan) σ

21 January 2018

1 reference

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.

21 January 2018

1 reference

Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

21 January 2018

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease

21 January 2018

1 reference

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group

21 January 2018

1 reference

Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study

21 January 2018

1 reference

Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy

21 January 2018

1 reference

Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C.

21 January 2018

1 reference

Liver stiffness diminishes with antiviral response in chronic hepatitis C.

21 January 2018

1 reference

Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C.

21 January 2018

1 reference

Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study

21 January 2018

1 reference

Non-invasive evaluation of liver fibrosis using transient elastography

21 January 2018

1 reference

Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C.

21 January 2018

1 reference

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection.

21 January 2018

1 reference

The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.

21 January 2018

1 reference

Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease

21 January 2018

1 reference

Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography

21 January 2018

1 reference

Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients

21 January 2018

1 reference

Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

21 January 2018

1 reference

Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir

21 January 2018

1 reference

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.

21 January 2018

1 reference

Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography

21 January 2018

1 reference

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

21 January 2018

1 reference

Comparison between the M and XL probes for liver fibrosis assessment by transient elastography.

21 January 2018

1 reference

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B

21 January 2018

1 reference